UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy

Martinez-Balibrea, E ; Abad, A ; Martínez-Cardús, A ; Ginés, A ; Valladares, M ; Navarro, M ; Aranda, E ; Marcuello, E ; Benavides, M ; Massutí, B ; Carrato, A ; Layos, L ; Manzano, J L ; Moreno, V

British journal of cancer, 2010-08, Vol.103 (4), p.581-589 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível